Sarepta Therapeutics (SRPT) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to 0.38.
- Sarepta Therapeutics' Equity Ratio rose 1140.74% to 0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38, marking a year-over-year increase of 1140.74%. This contributed to the annual value of 0.39 for FY2024, which is 4644.36% up from last year.
- Per Sarepta Therapeutics' latest filing, its Equity Ratio stood at 0.38 for Q3 2025, which was up 1140.74% from 0.37 recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Equity Ratio ranged from a high of 0.39 in Q4 2024 and a low of 0.12 during Q4 2022
- Moreover, its 5-year median value for Equity Ratio was 0.26 (2023), whereas its average is 0.26.
- Per our database at Business Quant, Sarepta Therapeutics' Equity Ratio tumbled by 5825.87% in 2022 and then soared by 11391.93% in 2023.
- Sarepta Therapeutics' Equity Ratio (Quarter) stood at 0.29 in 2021, then plummeted by 58.26% to 0.12 in 2022, then surged by 113.92% to 0.26 in 2023, then soared by 46.44% to 0.39 in 2024, then decreased by 1.97% to 0.38 in 2025.
- Its last three reported values are 0.38 in Q3 2025, 0.37 for Q2 2025, and 0.33 during Q1 2025.